126 related articles for article (PubMed ID: 34182253)
1. Generation and characterization of a control and patient-derived human iPSC line containing the Hermansky Pudlak type 2 (HPS2) associated heterozygous compound mutation in AP3B1.
Aarts CEM; Karampini E; Wüst T; Webbers S; Varga E; Geissler J; Voorberg J; von Lindern M; Bierings R; van den Akker E; Kuijpers TW
Stem Cell Res; 2021 Jul; 54():102444. PubMed ID: 34182253
[TBL] [Abstract][Full Text] [Related]
2. Hermansky-Pudlak syndrome type 2: Aberrant pre-mRNA splicing and mislocalization of granule proteins in neutrophils.
de Boer M; van Leeuwen K; Geissler J; van Alphen F; de Vries E; van der Kuip M; Terheggen SWJ; Janssen H; van den Berg TK; Meijer AB; Roos D; Kuijpers TW
Hum Mutat; 2017 Oct; 38(10):1402-1411. PubMed ID: 28585318
[TBL] [Abstract][Full Text] [Related]
3. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
[TBL] [Abstract][Full Text] [Related]
4. Defective AP-3-dependent VAMP8 trafficking impairs Weibel-Palade body exocytosis in Hermansky-Pudlak Syndrome type 2 blood outgrowth endothelial cells.
Karampini E; Schillemans M; Hofman M; van Alphen F; de Boer M; Kuijpers TW; van den Biggelaar M; Voorberg J; Bierings R
Haematologica; 2019 Oct; 104(10):2091-2099. PubMed ID: 30630984
[TBL] [Abstract][Full Text] [Related]
5. Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2.
Jones ML; Murden SL; Brooks C; Maloney V; Manning RA; Gilmour KC; Bharadwaj V; de la Fuente J; Chakravorty S; Mumford AD
BMC Med Genet; 2013 Apr; 14():42. PubMed ID: 23557002
[TBL] [Abstract][Full Text] [Related]
6. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1.
Wenham M; Grieve S; Cummins M; Jones ML; Booth S; Kilner R; Ancliff PJ; Griffiths GM; Mumford AD
Haematologica; 2010 Feb; 95(2):333-7. PubMed ID: 19679886
[TBL] [Abstract][Full Text] [Related]
7. Novel AP3B1 mutations in a Hermansky-Pudlak syndrome type2 with neonatal interstitial lung disease.
Matsuyuki K; Ide M; Houjou K; Shima S; Tanaka S; Watanabe Y; Tomino H; Egashira T; Takayanagi T; Tashiro K; Okamura K; Suzuki T; Miyamoto T; Shibata H; Yasumi T; Nishikomori R
Pediatr Allergy Immunol; 2022 Feb; 33(2):e13748. PubMed ID: 35212049
[No Abstract] [Full Text] [Related]
8. Generation of Hermansky Pudlak syndrome type 2 (HPS2) induced pluripotent stem cells (iPSCs).
Maguire JA; Lu L; Mills JA; Sullivan LM; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):287-9. PubMed ID: 27345985
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
[TBL] [Abstract][Full Text] [Related]
10. Novel mutation causing Hermansky-Pudlak Syndrome Type 2.
Chiang PW; Spector E; Thomas M; Frei-Jones M
Pediatr Blood Cancer; 2010 Dec; 55(7):1438. PubMed ID: 20981699
[No Abstract] [Full Text] [Related]
11. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S
Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622
[TBL] [Abstract][Full Text] [Related]
12. Reduced myeloid commitment and increased uptake by macrophages of stem cell-derived HPS2 neutrophils.
Webbers SD; Aarts CE; Klein B; Koops D; Geissler J; Tool AT; van Bruggen R; van den Akker E; Kuijpers TW
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38238087
[TBL] [Abstract][Full Text] [Related]
13. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2.
Jung J; Bohn G; Allroth A; Boztug K; Brandes G; Sandrock I; Schäffer AA; Rathinam C; Köllner I; Beger C; Schilke R; Welte K; Grimbacher B; Klein C
Blood; 2006 Jul; 108(1):362-9. PubMed ID: 16537806
[TBL] [Abstract][Full Text] [Related]
14. Defective HIV-1 particle assembly in AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2.
Liu L; Sutton J; Woodruff E; Villalta F; Spearman P; Dong X
J Virol; 2012 Oct; 86(20):11242-53. PubMed ID: 22875976
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids.
Korogi Y; Gotoh S; Ikeo S; Yamamoto Y; Sone N; Tamai K; Konishi S; Nagasaki T; Matsumoto H; Ito I; Chen-Yoshikawa TF; Date H; Hagiwara M; Asaka I; Hotta A; Mishima M; Hirai T
Stem Cell Reports; 2019 Mar; 12(3):431-440. PubMed ID: 30773483
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.
Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
Stem Cell Res; 2021 Aug; 55():102443. PubMed ID: 34237592
[TBL] [Abstract][Full Text] [Related]
17. Partial albinism and immunodeficiency in patients with Hermansky-Pudlak Type II: Introducing 2 novel mutations.
Alizadeh Z; Nabilou S; Mazinani M; Tajik S; Hamidieh AA; Houshmand M; Fazlollahi MR; Pourpak Z
Scand J Immunol; 2021 Jan; 93(1):e12966. PubMed ID: 32869296
[No Abstract] [Full Text] [Related]
18. The Ap3b1 gene regulates the ocular melanosome biogenesis and tyrosinase distribution differently from the Hps1 gene.
Jing R; Dong X; Li K; Yan J; Chen X; Feng L
Exp Eye Res; 2014 Nov; 128():57-66. PubMed ID: 25160823
[TBL] [Abstract][Full Text] [Related]
19. Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).
Maguire JA; Lu L; Mills JA; Sullivan LM; Gagne A; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):233-5. PubMed ID: 27345974
[TBL] [Abstract][Full Text] [Related]
20. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II.
Enders A; Zieger B; Schwarz K; Yoshimi A; Speckmann C; Knoepfle EM; Kontny U; Müller C; Nurden A; Rohr J; Henschen M; Pannicke U; Niemeyer C; Nurden P; Ehl S
Blood; 2006 Jul; 108(1):81-7. PubMed ID: 16551969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
